Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epiretinal membranes in patients with uveitis: an update on the current state of management. | Int Ophthalmol | 2024 | 38940960 | PubTator, text mining | PubMed |
| Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis. | Nat Commun | 2024 | 38897994 | PubTator, text mining | PubMed |
| Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration. | Ophthalmol Sci | 2024 | 38881603 | PubTator, text mining | PubMed |
| The Effect of Perinatal High-Dose Erythropoietin on Retinal Structural and Vascular Characteristics in Children Born Preterm. | Am J Ophthalmol | 2024 | 38880371 | PubTator, text mining | PubMed |
| Fluorescence saturation imaging microscopy: molecular fingerprinting with a standard confocal microscope. | Biomed Opt Express | 2024 | 38867799 | PubTator, text mining | PubMed |
| Enhancing Self-Supervised Learning for Rare Diseases in OCT-Reply. | JAMA Ophthalmol | 2024 | 38842855 | PubTator, text mining | PubMed |
| The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema. | Graefes Arch Clin Exp Ophthalmol | 2024 | 38771336 | PubTator, text mining | PubMed |
| Vitreoretinal Interface Cells Correlate In Vivo With Uveitis Activity and Decrease With Anti-Inflammatory Treatment. | Transl Vis Sci Technol | 2024 | 38767904 | PubTator, text mining | PubMed |
| Precision in IOL Calculation for Cataract Patients with Prior History of Combined RK and LASIK Histories. | Clin Ophthalmol | 2024 | 38741583 | PubTator, text mining | PubMed |
| Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor. | BMC Cancer | 2024 | 38698344 | PubTator, text mining | PubMed |
| In silico modeling for ex vivo placenta perfusion of nicotine. | Front Pharmacol | 2024 | 38681194 | PubTator, text mining | PubMed |
| Clinical application of multicolor scanning laser ophthalmology in diagnosis and grading of central retinal artery occlusion. | Front Neurosci | 2024 | 38660228 | PubTator, text mining | PubMed |
| TIN2-mediated reduction of mitophagy induces RPE senescence under high glucose. | Cell Signal | 2024 | 38657846 | PubTator, text mining | PubMed |
| Morph-SSL: Self-Supervision With Longitudinal Morphing for Forecasting AMD Progression From OCT Volumes. | IEEE Trans Med Imaging | 2024 | 38635383 | PubTator, text mining | PubMed |
| Quantitative evaluation of OCT angiography images in healthy and glaucomatous subjects through a novel approach: exploring inter-image variability. | Eye (Lond) | 2024 | 38615097 | PubTator, text mining | PubMed |
| Reduced Retinal Blood Vessel Densities Measured by Optical Coherence Tomography Angiography in Keratoconus Patients Are Negatively Correlated with Keratoconus Severity. | Diagnostics (Basel) | 2024 | 38611620 | PubTator, text mining | PubMed |
| Transparency in Artificial Intelligence Reporting in Ophthalmology-A Scoping Review. | Ophthalmol Sci | 2024 | 38591048 | PubTator, text mining | PubMed |
| Retinal Ischemic Perivascular Lesions Are Associated With Myocardial Infarction in Patients With Coronary Artery Disease. | Am J Ophthalmol | 2024 | 38552932 | PubTator, text mining | PubMed |
| Structure and function of Semaphorin-5A glycosaminoglycan interactions. | Nat Commun | 2024 | 38548715 | PubTator, text mining | PubMed |
| Novel features of degenerative retinoschisis identified using ultra-widefield multicolor channels: A review of 139 eyes. | Acta Ophthalmol | 2024 | 38533620 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=13